Variation in guideline decision-making: a cross-sectional study of oncology compendium panels.
Variation in guideline decision-making: a cross-sectional study of oncology compendium panels. Health Aff Sch. 2026 Aug; 4(8):qxag215.
PMID: 42643837
Importance of Inclusion of Representative Populations in Pivotal Clinical Trials: Zolbetuximab as an Example.
Importance of Inclusion of Representative Populations in Pivotal Clinical Trials: Zolbetuximab as an Example. J Clin Oncol. 2026 Oct 10; 44(29):2773-2776.
PMID: 42555895
From cabozantinib to zanzalintinib: obvious chemical modifications as a new frontier in product hopping.
From cabozantinib to zanzalintinib: obvious chemical modifications as a new frontier in product hopping. Nat Biotechnol. 2026 Aug; 44(8):1274-1279.
PMID: 42581119
Envisioning Low-Dose Tarlatamab.
Envisioning Low-Dose Tarlatamab. JTO Clin Res Rep. 2026 Sep; 7(9):101042.
PMID: 42657300
Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation.
Evaluating Perceived Value of Pharmacogenomic Testing After a Personalized Therapeutics Clinic Consultation. Clin Transl Sci. 2026 04; 19(4):e70537.
PMID: 41949895
Ivonescimab: The Next United States Food and Drug Administration Project Optimus Flashpoint?
Ivonescimab: The Next United States Food and Drug Administration Project Optimus Flashpoint? JTO Clin Res Rep. 2026 Jul; 7(7):100976.
PMID: 42394715
TPMT-Cisplatin: Lessons in Citation Integrity and Scientific Oversight.
TPMT-Cisplatin: Lessons in Citation Integrity and Scientific Oversight. JCO Oncol Pract. 2026 Feb 04; OP2500913.
PMID: 41637682
Dear Doctor: We Still Have No Idea of What Dose of Capecitabine You Should Prescribe.
Dear Doctor: We Still Have No Idea of What Dose of Capecitabine You Should Prescribe. J Clin Oncol. 2026 May; 44(13):1186-1189.
PMID: 41610386
Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer.
Opportunities for Harmonization of US Food and Drug Administration Regulatory Decisions Exemplified by the Traditional Approval of Sotorasib and Panitumumab for Colorectal Cancer. J Clin Oncol. 2026 Jan 10; 44(2):81-85.
PMID: 41348990
Potential alternative dosage strategies for patent-protected oral cancer drugs.
Potential alternative dosage strategies for patent-protected oral cancer drugs. Eur J Cancer. 2025 Nov 17; 230:116067.
PMID: 41138352